Insurance authorization and access to proton therapy for patients with head and neck cancers
CONCLUSIONS: BIPOC patients were significantly more likely to have insurance plans unfavorable to proton therapy coverage. These PU insurance plans were associated with a longer median time to determination, a lower approval rate for proton therapy, and a longer time to start radiation of any modality.PMID:36889515 | DOI:10.1016/j.ijrobp.2023.02.033
Source: Health Physics - Category: Physics Authors: Mark W McDonald James E Bates Neal S McCall Subir Goyal Yuan Liu Soumon Rudra Jill S Remick Sibo Tian Mark W El-Deiry Nabil F Saba William A Stokes Erica Swinney Source Type: research
More News: Cancer | Cancer & Oncology | Head and Neck Cancer | Insurance | Medicare | Physics | Proton Therapy